CN112843172A - Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method - Google Patents

Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method Download PDF

Info

Publication number
CN112843172A
CN112843172A CN202110247850.1A CN202110247850A CN112843172A CN 112843172 A CN112843172 A CN 112843172A CN 202110247850 A CN202110247850 A CN 202110247850A CN 112843172 A CN112843172 A CN 112843172A
Authority
CN
China
Prior art keywords
parts
chinese
medicine composition
western medicine
raw materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110247850.1A
Other languages
Chinese (zh)
Inventor
郭宝叶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110247850.1A priority Critical patent/CN112843172A/en
Publication of CN112843172A publication Critical patent/CN112843172A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/52Juglandaceae (Walnut family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285Aucklandia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a Chinese and western medicine composition for improving human body function and discharging harmful toxin, which is prepared from the following raw materials in parts by weight: 15-25 parts of cyclocarya paliurus leaves, 15-25 parts of golden camellia, 15-25 parts of seabuckthorn leaves, 15-25 parts of polygonatum odoratum, 25-35 parts of radix puerariae, 15-25 parts of wolfberry fruits, 35-45 parts of mazzing, 15-25 parts of saussurea involucrate cultures, 15-25 parts of chitosan oligosaccharides, 7-15 parts of yeast B-glucose, 7-15 parts of fructo-oligosaccharides, 7-15 parts of phytosterol, 8-15 parts of guarana extracts and 7-15 parts of grape seed extracts. The Chinese and western medicinal composition has effects of improving body instinct, improving cardiovascular system, dilating coronary artery blood vessel, reducing blood lipid, and improving systemic microcirculation.

Description

Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method
Technical Field
The present invention relates to a Chinese and western medicine composition for raising human body function and discharging harmful toxin.
Background
Along with the improvement of living standard of people, ingested food is more and more exquisite, the contained nutrient substances are more and more abundant, the types of food are rich and colorful, the food is processed by a series of cooking modes such as frying, roasting and the like, the food processing is more and more exquisite, and simultaneously, a great burden is brought to the body, so that the body instinct is reduced, and then a series of cardiovascular diseases such as cardiovascular sclerosis, coronary atherosclerosis, dyslipidemia and systemic microcirculation disturbance, coronary heart disease, hyperlipidemia, hypertension, diabetes and the like are caused, and sub-health symptoms such as insomnia, dreaminess, body fatigue, weakness and the like are caused. Therefore, how to effectively improve the instinct of the human body, improve the elasticity of blood vessels, reduce blood fat, expand coronary arteries, improve microcirculation, provide energy for cardiovascular energy recovery and improve the instinct of the human body is a problem which is urgently needed to be solved at present.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a Chinese and western medicine composition for improving the human body function and discharging harmful toxins, and the Chinese and western medicine composition can improve the blood vessel elasticity, reduce the blood fat, expand the coronary artery, improve the microcirculation, provide energy for cardiovascular recovery and improve the human body instinct by utilizing the medicine-food homology theory and combining Chinese and western medicines.
In order to solve the technical problems, the Chinese and western medicine composition for improving the human body function and discharging the harmful toxin is characterized in that the Chinese and western medicine composition is prepared from the following raw materials in parts by weight: 15-25 parts of cyclocarya paliurus leaves, 15-25 parts of golden camellia, 15-25 parts of seabuckthorn leaves, 15-25 parts of polygonatum odoratum, 25-35 parts of radix puerariae, 15-25 parts of wolfberry fruits, 35-45 parts of mazzing, 15-25 parts of saussurea involucrate cultures, 15-25 parts of chitosan oligosaccharides, 7-15 parts of yeast B-glucose, 7-15 parts of fructo-oligosaccharides, 7-15 parts of phytosterol, 8-15 parts of guarana extracts and 7-15 parts of grape seed extracts.
More precisely, 18-22 parts of cyclocarya paliurus leaves, 17-21 parts of golden camellia, 18-22 parts of seabuckthorn leaves, 17-21 parts of polygonatum odoratum, 28-31 parts of kudzuvine roots, 18-22 parts of barbary wolfberry fruits, 38-41 parts of mazzing, 18-22 parts of saussurea involucrate cultures, 18-22 parts of chitosan oligosaccharides, 9-11 parts of yeast B-glucose, 8-11 parts of fructo-oligosaccharides, 9-12 parts of phytosterol, 8-12 parts of guarana extracts and 8-12 parts of grape seed extracts.
More precisely, 20 parts of cyclocarya paliurus leaves, 20 parts of golden camellia, 20 parts of seabuckthorn leaves, 20 parts of polygonatum odoratum, 30 parts of radix puerariae, 20 parts of wolfberry fruits, 40 parts of mazzuo, 20 parts of saussurea involucrate cultures, 20 parts of chitosan oligosaccharides, 10 parts of yeast B-glucose, 10 parts of fructooligosaccharides, 10 parts of phytosterol, 10 parts of guarana extracts and 10 parts of grape seed extracts.
The existing traditional Chinese medicine theory considers that: the etiology and pathogenesis of coronary heart disease belong to the categories of chest stuffiness, true heart pain, net heart pain and the like in traditional Chinese medicine, and similar records are available in the early epoch. The book Su Wen & Tibetan Qi method treatise also states that the patient with heart disease, pain in the chest, hypochondriac fullness, hypochondriac pain, pain between the scapular region of the back of the body, and pain in the two arms. The book Ling Shu Jue Lun states that the pain of the heart is true, the limbs are green to the joints, the heart pain is basic, タ death occurs after one day, and タ death occurs after one day. The true heart pain is the severe chest stuffiness. The main pathogenesis of coronary heart disease is the obstruction of blood vessels, which is caused by blood, disease turbidity, qi stagnation and congealing cold, and the generation of blood, disease turbidity, qi stagnation and congealing cold is the result of viscera dysfunction for a long time, so that the heart governs blood vessels, heart diseases are considered to be closely related to blood and vessels, and the treatment is started from two ways of blood and vessels. That is, to solve the problem of coronary heart disease, a series of problems caused by the improvement of the body's instinct, the restoration of the vascular circulation, the provision of energy for cardiovascular recovery and the alleviation of the systemic microcirculation disturbance are achieved by simultaneously regulating the systemic vascular circulation, improving the vascular elasticity, removing lipid deposition in the blood and regulating the five internal organs.
In the Chinese and western medicine composition, the original traditional method that all Chinese medicines are adopted is broken through, partial western medicines are added into the Chinese and western medicine composition, the western medicines (extracts or cultures) are used as menses-inducing medicines, and the medicines in the Chinese and western medicine composition can reach the disease focus by supplementing nutrition and eliminating lipid deposition in blood. The application of each medicine is explained by the action mechanism of each medicine in the above formula.
1. Reducing blood fat and maintaining blood fat balance: contains chitosan, Camellia Chysantha, rhizoma Polygonati Odorati, folium cyclocarya paliurus, and fructus Lycii, and contains flavonoid compounds and polysaccharide which can remove in vivo excessive cholesterol and maintain blood lipid balance.
Chitosan oligosaccharide: the positive charge of the chitosan oligosaccharide can interact with cholesterol, bile acid and lipid with negative charge on the surface to form insoluble floccule. But it is not hydrolyzed by enzymes in the pancreas or intestinal tract, thereby blocking the hepatic-intestinal circulation of bile acids and accelerating its excretion into feces. Absorption of cholesterol is reduced and as hepatic bile acids are depleted, more hepatic cholesterol is turned to be used for bile acid production. Low-density lipoprotein (LDL) receptor lipoprotein (apo B/E) is activated. Stimulation of the LDL receptor apolipoprotein B/E activity increases LDL cholesterol metabolism, resulting in a decrease in plasma LDL cholesterol levels.
The rhizoma Polygonati Odorati comprises rhizoma Polygonati Odorati polysaccharide as main ingredient. Firstly, tranquilizing nerves and strengthening heart: yuzhu mucopolysaccharide, Yuzhu fructan, etc., and has effects of improving myocardial anoxia and adrenocortical hormone-like effect. ② reducing blood fat and blood sugar: inhibit hepatic glycolysis system, and inhibit blood glucose increase caused by glucose and alloxan. Wherein the polygonatum medicine has the function of reducing low-density lipoprotein and the function of reducing blood sugar, thereby effectively preventing the occurrence of diabetes.
Wolfberry fruit: wolfberry polysaccharide: is a water-soluble polysaccharide, is the main active component in the medlar, and has the functions of promoting immunity, resisting aging, resisting tumor, eliminating free radicals, resisting fatigue, resisting radiation, protecting liver, protecting and improving reproductive function, and the like. ② betaine: is one of the main alkaloids in fructus Lycii, leaf and stalk, and has effects on lipid metabolism or fatty liver resistance mainly due to betaine contained therein, which acts as methyl donor in vivo. ③ medlar pigment: is various color-developing substances existing in medlar berries and is an important physiological active ingredient of medlar seeds. Mainly including carotene, lutein and other colored substances. The carotenoid contained in the medlar has very important medicinal value. Many studies have proved that the lycium barbarum seed pigment has the effects of improving the human body immunity, preventing and inhibiting tumors, preventing atherosclerosis and the like.
Cyclocarya paliurus leaves: the blood fat reducing effect: researches find that the cyclocarya paliurus leaves contain effective components such as saponin, triterpene, flavone and polysaccharide, and have a good blood fat reducing effect. Especially, the trace element selenium can effectively improve lipid metabolism and has obvious inhibiting effect on the rise of serum total cholesterol in human bodies. ② antioxidation: the combination of sun drying and vitamin E in cyclocarya paliurus is an important in-vivo free radical cleaning agent. Research shows that the organic germanium has the function of resisting lipid oxidation.
Golden camellia: the Camellia nitidissima saponin content is 6300mg/kg, and the Camellia nitidissima saponin can strengthen heart, relax blood vessel, relieve fatigue, slow heart rate and double-phase blood pressure, and promote biosynthesis of DNA, protein and lipid. The total flavone content of the golden camellia is 4400mg/kg, coronary vessels are dilated, hypertension is reduced, systole is enhanced, the number of heart beats is reduced, cholesterol is reduced, and diuresis is promoted. The Camellia nitidissima contains abundant tea pigment, and can be used for improving blood microcirculation disturbance. Reducing cholesterol and triglyceride, and increasing high density lipoprotein, and can be used for preventing and treating DM complications, such as cardiovascular disease, cerebrovascular disease, and atherosclerosis.
Fructo-oligosaccharide: is a water-soluble dietary fiber, and can reduce serum cholesterol and improve lipid metabolism after long-term administration. The fructo-oligosaccharide is an excellent water-soluble dietary fiber, can effectively reduce the amount of serum cholesterol, triglyceride and free fatty acid, and has good improving effect on a series of cardiovascular diseases such as hypertension, arteriosclerosis and the like caused by high blood fat.
Yeast B-glucose regulates blood fat. Researches show that the yeast glucan can obviously reduce the triglyceride level of a human body, reduce the LDL (low density lipoprotein) level and increase the HDL (high density lipoprotein) level, and effectively prevent cardiovascular and cerebrovascular diseases such as coronary heart disease, arteriosclerosis, cerebral apoplexy and the like; secondly, reducing cholesterol, preventing and treating lithiasis, when the yeast B glucan enters a human body, the unique triple helix structure of the yeast B glucan determines that the yeast B glucan is not hydrolyzed into monosaccharides such as glucose and the like in the gastrointestinal tract (so that the yeast B glucan has no influence on diabetes patients taking beta-1, 3 and 1, 6-glucan), is combined with a specific receptor, passes through intestinal epithelium finally to enter a lymphatic system through endocytosis (or endocytosis), and enters a blood system from the lymphatic system to play a role. The cholesterol in the liver is converted into cholic acid, the cholic acid can help digestion lipid control when reaching the small intestine, then the cholic acid can be absorbed by the small intestine and returned to the liver to be converted into the cholesterol, and since yeast glucan as dietary fiber can form colloidal substances in the small intestine to surround the cholic acid, the cholic acid cannot be absorbed back to the liver through the wall of the small intestine, but is discharged out of the body through the digestive tract, so when the cholic acid is needed by the re-digestion of food in the intestinal tract, the liver can only supplement the consumed cholic acid by absorbing the cholesterol in the blood, and the cholesterol in the blood is reduced. The beta-glucan has the functions of absorbing bile acid and promoting bile acid to be discharged out of a body, promotes the conversion of cholesterol into bile acid, maintains the inherent normal metabolism of cholesterol, effectively inhibits the rise of cholesterol in serum, and prevents and treats in-vivo calculus diseases.
2. Dilating coronary artery, improving myocardial blood circulation, reducing blood lipid, protecting myocardium.
Folium Hippophae: the fructus Hippophae flavone has effects of improving myocardial microcirculation, reducing oxygen consumption of myocardium, resisting angiosclerosis, and resisting inflammation.
Kudzu root: the flavone and puerarin contained in radix Puerariae have effects of improving myocardial oxygen metabolism, dilating blood vessel, improving microcirculation, and reducing resistance of blood vessel, and can be used for preventing and treating myocardial infarction, myocardial ischemia, arrhythmia, hypertension, and arteriosclerosis. Puerarin has obvious effect of lowering blood sugar, and flavonoid compounds have effect of lowering blood lipid, can help to lower harmful substances such as cholesterol in human body, and has obvious effect of treating hyperglycemia, hyperlipemia and the like.
Purslane: purslane contains rich active substances such as L-norepinephrine, dopamine, dopa and the like. Norepinephrine can stimulate the vascular B-receptor. It can promote blood vessel contraction, increase blood pressure, increase perfusion pressure of coronary artery, and increase coronary flow. In addition, these substances stimulate the B-receptors of the heart, which leads to an increase in myocardial contractility and the automatic rhythm of the heart. And the health-care wine contains rich fatty acid, can inhibit the generation of serum cholesterol and triglyceride in a human body, reduce the blood viscosity, promote the vasodilatation, and prevent platelet aggregation, coronary artery and thrombosis, thereby playing the role of preventing and treating heart diseases.
3. The grape seeds, anthocyanin and other components can eliminate free radicals in vivo, have the function of antioxidation, help to improve the microcirculation of the whole body to a certain extent and delay the aging of the organism.
Guarana extract: guarana contains abundant glucose, amino acids, and fatty acids, and is decomposed in cytoplasm to form energy-variable form, and transferred to glandular granule of energy-generating system for ATP synthesis, so as to activate cells continuously, maintain electrolyte balance, and stabilize cell membrane.
Grape seed extract: the main component is grape polyphenol, which is a nutrient substance extracted from grape seeds. It comprises several different forms of anthocyanidin precursors, the mixture of which is oligomeric proanthocyanidins, also known as procyanidins. The grape seeds have strong oxidation resistance and activity, and can remove free radicals in vivo. Because free radicals and oxidative stress are important reasons causing a plurality of cardiovascular and cerebrovascular diseases, OPC can directly remove oxygen radicals in blood vessels through strong antioxidant activity, reduce oxidative stress injury in the ischemia-reperfusion process and protect the cardiovascular and cerebrovascular systems.
Saussurea involucrate culture: the herba Saussureae Involueratae culture has antiinflammatory, antibacterial, immunity improving, radioprotective, ultraviolet ray preventing, antifatigue, antioxidant, skin whitening, and blood lipid regulating effects.
In the formula, the monarch drugs including chitosan, golden camellia, polygonatum, cyclocarya paliurus leaves and medlar contain flavonoid compounds, polysaccharide and other components which can remove redundant cholesterol in the body and maintain blood fat balance; the puerarin, seabuckthorn flavone, anthocyanin, flavonoid compounds and other components contained in the kudzuvine root, the seabuckthorn, the golden camellia and the like can expand coronary vessels, improve myocardial blood circulation, simultaneously have the function of reducing blood fat, strengthen the function of reducing blood fat of monarch drugs and increase the protection of cardiac muscle; the grape seeds, anthocyanin and other components can eliminate free radicals in vivo, have the function of antioxidation, have certain help to improve the microcirculation of the whole body, and simultaneously strengthen the functions of monarch drugs and adjuvant drugs.
The saussurea involucrate culture is a technology for culturing isolated plant organs, tissues, cells, embryos or protoplasts of saussurea involucrate on an artificially prepared culture medium under an aseptic condition, and culturing under an artificially controlled condition to increase the tissue or cell value and further culturing according to the requirement; or a culture produced by dedifferentiating it to produce callus and then gradually differentiating the organ and growing into a whole plant.
The saussurea involucrate culture and the grape seed extract are corresponding products produced by Ningshan national Sage Biotechnology GmbH which meet the inspection standard, of course, the components can also be products produced by other GmbH, and each component meets the corresponding data on the inspection report. The guarana extract is imported from brazil of saint biotechnology limited of the country of Ningshan, and the product is imported from Utility development company of Shanghai.
A preparation method of a Chinese and western medicine composition for improving human body function and discharging harmful toxin is characterized by comprising the following steps:
1) selecting raw materials of a Chinese and western medicine composition, namely 15-25 parts of cyclocarya paliurus leaves, 15-25 parts of golden camellia, 15-25 parts of seabuckthorn leaves, 15-25 parts of polygonatum odoratum, 25-35 parts of kudzuvine roots, 15-25 parts of barbary wolfberry fruits, 35-45 parts of mazzing and 15-25 parts of saussurea involucrate cultures, cleaning various raw materials to remove impurities, humidifying and controlling the humidity to be 14.5%;
2) fully mixing the raw materials in the proportion, using puffing equipment, controlling the temperature to be 130-170 ℃, realizing instant puffing, and then baking for 20-50 minutes by using an oven at the temperature of 130-170 ℃;
3) putting the puffed and baked raw materials into a pulverizer, and pulverizing to 70-100 meshes to obtain raw material powder;
4) the following materials are added into the raw material powder: 15-25 parts of chitosan oligosaccharide, 7-15 parts of yeast B-glucose, 7-15 parts of fructo-oligosaccharide, 7-15 parts of phytosterol, 8-15 parts of guarana extract and 7-15 parts of grape seed extract, fully and uniformly stirring, and tabletting and packaging to obtain the finished product of the Chinese and western medicine composition.
The prepared Chinese and western medicine composition comprises the following components:
Figure 620129DEST_PATH_IMAGE001
the curative effect of the Chinese and western medicine composition is further verified by clinical tests.
The subjects are the people with cardiovascular system diseases and discomfort such as palpitation, chest distress, suffocation, dyslipidemia and the like caused by the reduction of the instinct of the cardiovascular system, wherein 30 percent of the trial groups are office workers who often shift when the work and rest are irregular, 30 percent of the trial groups are old people with long-term smoking and drinking history, 40 percent of the trial groups are middle-aged people with greasy diet, and the sex proportion is equal. The group of subjects having substantially the same age and sex was set as a control group. The subjects in the experimental group took the tablet of the present invention for 30 days, during which they did not take any medicine according to the original life rule and diet. During the control group period, no drug was taken according to the original life rule and diet.
The medicine is taken for 30 days due to special reasons such as cold and fever, and the crowd departing from the test group is not more than 10 percent.
And (4) judging a result: improving chronic cardiovascular system diseases: the examination results of the test food groups before and after the experiment are all improved, and symptoms caused by cardiovascular system diseases such as palpitation, chest distress, breath holding, dyslipidemia and the like are all improved. The symptoms before and after the control group are not improved, and the Chinese and western medicine composition has the function of improving the cardiovascular system diseases.
Detailed Description
Example 1
A Chinese and western medicine composition for improving human body function and discharging harmful toxin comprises the following raw materials in parts by weight:
15 parts of cyclocarya paliurus leaves, 15 parts of golden camellia, 15 parts of seabuckthorn leaves, 15 parts of polygonatum odoratum, 25 parts of radix puerariae, 15 parts of wolfberry fruits, 35 parts of mazerana, 15 parts of saussurea involucrate cultures, 15 parts of chitosan oligosaccharides, 7 parts of yeast B-glucose, 7 parts of phytosterol, 8 parts of guarana extracts and 7 parts of grape seed extracts.
The preparation method of the finished product of the Chinese and western medicine composition comprises the following steps:
1) selecting raw materials of a Chinese and western medicine composition, namely 15 parts of cyclocarya paliurus leaves, 15 parts of golden camellia, 15 parts of seabuckthorn leaves, 15 parts of polygonatum odoratum, 25 parts of radix puerariae, 15 parts of wolfberry fruits and 35 parts of mazzing, cleaning and removing impurities of the raw materials, humidifying and controlling the humidity to be 14.5%;
2) fully mixing the raw materials in the proportion, using puffing equipment, controlling the temperature to be 130 ℃, realizing instant puffing, and then baking for 20 minutes by using an oven at the temperature of 130 ℃;
3) putting the puffed and baked raw materials into a pulverizer, and pulverizing to 70 meshes to obtain raw material powder;
4) the following materials are added into the raw material powder: 15 parts of saussurea involucrate culture, 15 parts of chitosan oligosaccharide, 7 parts of yeast B-glucose, 7 parts of fructo-oligosaccharide, 7 parts of phytosterol, 8 parts of guarana extract and 7 parts of grape seed extract, fully and uniformly stirring, and tabletting and packaging to obtain the finished product of the Chinese and western medicine composition.
Example 2
A Chinese and western medicine composition for improving human body function and discharging harmful toxin comprises the following raw materials in parts by weight:
18 parts of cyclocarya paliurus leaves, 18 parts of golden camellia, 18 parts of seabuckthorn leaves, 18 parts of polygonatum odoratum, 20 parts of radix puerariae, 18 parts of wolfberry fruits, 30 parts of mayesons, 15 parts of saussurea involucrate cultures, 15 parts of chitosan oligosaccharides, 7 parts of yeast B-glucose, 15 parts of phytosterol, 8 parts of guarana extracts and 15 parts of grape seed extracts.
The preparation method of the finished product of the Chinese and western medicine composition comprises the following steps:
1) selecting raw materials of a Chinese and western medicine composition, namely 18 parts of cyclocarya paliurus leaves, 18 parts of golden camellia, 18 parts of seabuckthorn leaves, 18 parts of polygonatum odoratum, 20 parts of radix puerariae, 18 parts of wolfberry fruits and 30 parts of mazzing, cleaning and removing impurities of the raw materials, humidifying and controlling the humidity to be 14.5%;
2) fully mixing the raw materials in the proportion, using puffing equipment, controlling the temperature to be 170 ℃, realizing instant puffing, and then baking for 50 minutes by using an oven at the temperature of 170 ℃;
3) putting the puffed and baked raw materials into a pulverizer, and pulverizing to 100 meshes to obtain raw material powder;
4) the following materials are added into the raw material powder: 25 parts of saussurea involucrate culture, 25 parts of chitosan oligosaccharide, 15 parts of yeast B-glucose, 7 parts of fructo-oligosaccharide, 7 parts of phytosterol, 8 parts of guarana extract and 7 parts of grape seed extract, fully and uniformly stirring, and tabletting and packaging to obtain the finished product of the Chinese and western medicine composition.
Example 3
A Chinese and western medicine composition for improving human body function and discharging harmful toxin comprises the following raw materials in parts by weight:
20 parts of cyclocarya paliurus leaves, 20 parts of golden camellia, 20 parts of sea buckthorn, 20 parts of polygonatum odoratum, 20 parts of radix puerariae, 20 parts of fructus lycii, 30 parts of mazzing, 10 parts of saussurea involucrate culture, 10 parts of chitosan oligosaccharide, 10 parts of yeast B-glucose, 7 parts of phytosterol, 8 parts of guarana extract and 7 parts of grape seed extract.
The preparation method of the finished product of the Chinese and western medicine composition comprises the following steps:
1) selecting raw materials of a Chinese and western medicine composition, namely 20 parts of cyclocarya paliurus leaves, 20 parts of golden camellia, 20 parts of sea buckthorn, 20 parts of polygonatum odoratum, 20 parts of radix puerariae, 20 parts of wolfberry fruits and 30 parts of purslane, cleaning and removing impurities from various raw materials, humidifying and controlling the dryness and humidity of the raw materials to be 14.5%;
2) fully mixing the raw materials in the proportion, using puffing equipment, controlling the temperature to be 150 ℃, realizing instant puffing, and then baking for 30 minutes by using an oven at the temperature of 150 ℃;
3) putting the puffed and baked raw materials into a pulverizer, and pulverizing to 80 meshes to obtain raw material powder;
4) the following materials are added into the raw material powder: 10 parts of saussurea involucrate culture, 10 parts of chitosan oligosaccharide, 15 parts of yeast B-glucose, 15 parts of fructo-oligosaccharide, 18 parts of phytosterol, 15 parts of guarana extract and 15 parts of grape seed extract, fully and uniformly stirring, and tabletting and packaging to obtain the finished product of the Chinese and western medicine composition.

Claims (5)

1. A Chinese and western medicine composition for improving human body function and discharging harmful toxin is characterized in that the Chinese and western medicine composition is prepared from the following raw materials in parts by weight:
15-25 parts of cyclocarya paliurus leaves, 15-25 parts of golden camellia, 15-25 parts of seabuckthorn leaves, 15-25 parts of polygonatum odoratum, 25-35 parts of radix puerariae, 15-25 parts of wolfberry fruits, 35-45 parts of mazzing, 15-25 parts of saussurea involucrate cultures, 15-25 parts of chitosan oligosaccharides, 7-15 parts of yeast B-glucose, 7-15 parts of phytosterol, 8-15 parts of guarana extracts and 7-15 parts of grape seed extracts.
2. The Chinese-western medicine composition for improving human body function and discharging harmful toxins according to claim 1, which is characterized in that the raw materials for preparing the Chinese-western medicine composition and the weight ratio thereof comprise:
18-22 parts of cyclocarya paliurus leaves, 17-21 parts of golden camellia, 18-22 parts of seabuckthorn leaves, 17-21 parts of polygonatum odoratum, 28-31 parts of radix puerariae, 18-22 parts of wolfberry fruits, 38-41 parts of mazzing, 18-22 parts of saussurea involucrate cultures, 18-22 parts of chitosan oligosaccharides, 9-11 parts of yeast B-glucose, 9-12 parts of phytosterol, 8-12 parts of guarana extracts and 8-12 parts of grape seed extracts.
3. The Chinese-western medicine composition for improving human body function and discharging harmful toxins according to claim 1, which is characterized in that the raw materials for preparing the Chinese-western medicine composition and the weight ratio thereof comprise:
20 parts of cyclocarya paliurus leaves, 20 parts of golden camellia, 20 parts of seabuckthorn leaves, 20 parts of polygonatum odoratum, 30 parts of radix puerariae, 20 parts of wolfberry fruits, 40 parts of mazzing, 20 parts of saussurea involucrate cultures, 20 parts of chitosan oligosaccharides, 10 parts of yeast B-glucose, 10 parts of phytosterol, 10 parts of guarana extracts and 10 parts of grape seed extracts.
4. A pharmaceutical composition for enhancing body functions and expelling noxious toxins according to any one of claims 1 to 3, wherein: the saussurea involucrate culture is a technology for culturing isolated plant organs, tissues, cells, embryos or protoplasts of saussurea involucrate on an artificially prepared culture medium under an aseptic condition, and culturing under an artificially controlled condition to increase the tissue or cell value and further culturing according to the requirement; or a culture produced by dedifferentiating it to produce callus and then gradually differentiating the organ and growing into a whole plant.
5. A preparation method of a Chinese and western medicine composition for improving human body function and discharging harmful toxin is characterized by comprising the following steps:
1) selecting raw materials of a Chinese and western medicine composition, namely 15-25 parts of cyclocarya paliurus leaves, 15-25 parts of golden camellia, 15-25 parts of seabuckthorn leaves, 15-25 parts of polygonatum odoratum, 25-35 parts of kudzuvine roots, 15-25 parts of barbary wolfberry fruits, 35-45 parts of mazzing and 15-25 parts of saussurea involucrate cultures, cleaning various raw materials to remove impurities, humidifying and controlling the humidity to be 14.5%;
2) fully mixing the raw materials in the proportion, using puffing equipment, controlling the temperature to be 130-170 ℃, realizing instant puffing, and then baking for 20-50 minutes by using an oven at the temperature of 130-170 ℃;
3) putting the puffed and baked raw materials into a pulverizer, and pulverizing to 70-100 meshes to obtain raw material powder;
4) the following materials are added into the raw material powder: 15-25 parts of chitosan oligosaccharide, 7-15 parts of yeast B-glucose, 7-15 parts of fructo-oligosaccharide, 7-15 parts of phytosterol, 8-15 parts of guarana extract and 7-15 parts of grape seed extract, fully and uniformly stirring, and tabletting and packaging to obtain the finished product of the Chinese and western medicine composition.
CN202110247850.1A 2021-03-06 2021-03-06 Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method Pending CN112843172A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110247850.1A CN112843172A (en) 2021-03-06 2021-03-06 Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110247850.1A CN112843172A (en) 2021-03-06 2021-03-06 Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method

Publications (1)

Publication Number Publication Date
CN112843172A true CN112843172A (en) 2021-05-28

Family

ID=75994187

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110247850.1A Pending CN112843172A (en) 2021-03-06 2021-03-06 Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method

Country Status (1)

Country Link
CN (1) CN112843172A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115708533A (en) * 2022-10-19 2023-02-24 华宝本草生物科技(海南)有限公司 Functional tea for preventing and improving cardiovascular and cerebrovascular diseases and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111214642A (en) * 2018-11-23 2020-06-02 河南旭仁堂生物科技有限公司 Traditional Chinese medicine composition for dredging microcirculation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111214642A (en) * 2018-11-23 2020-06-02 河南旭仁堂生物科技有限公司 Traditional Chinese medicine composition for dredging microcirculation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115708533A (en) * 2022-10-19 2023-02-24 华宝本草生物科技(海南)有限公司 Functional tea for preventing and improving cardiovascular and cerebrovascular diseases and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101695376B (en) Health-care food for preventing diabetes
US8372447B2 (en) Compositions and methods for promoting weight loss and increasing energy
CN101253903B (en) Health food with fat-reducing function and its preparation
CN108112996A (en) A kind of alimentation composition for controlling diabetes B crowd hyperglycaemia and improving immunity
CN101822749B (en) Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof
CN102038126B (en) Health-care food for regulating blood fat and comprehensively antagonizing atherosclerosis and preparation method thereof
CN101579120A (en) Nutritional food with weight-losing function and preparation method thereof
CN109966417A (en) A kind of solid beverage for diabetic population
CN102511869A (en) Thickened red jujube ginger pulp
CN105232907A (en) Beverage capable of invigorating kidney and strengthening Yang and making method thereof
CN106562428A (en) Facial beautification and body shaping soft extract and preparation method thereof
CN115317574A (en) Composition for treating hyperuricemia and application thereof
CN106539083A (en) It is a kind of to be used to prevent and treat diabetic retinopathy, alleviate asthenopic compositionss
CN107751993A (en) A kind of antifatigue cream taste and preparation method thereof
CN104857154A (en) Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor
CN101711840B (en) Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof
CN112843172A (en) Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method
CN107802770A (en) Balance the Chinese medicine and health products of metabolic system radical cure early stage type II diabetes
CN112516206A (en) Composition for reducing high blood pressure, high blood sugar and high blood fat, traditional Chinese medicine preparation and application
CN102090637A (en) Collagen-containing compound nutritious powder
CN101284096A (en) Sheep placenta capsule compound nest-defence capsule for beautifying face
CN110237117A (en) A kind of soft capsule and preparation method thereof of Menopause anti-aging
CN104256618B (en) A kind of hypoglycemic food, health products or pharmaceutical composition
CN103181557A (en) Nutritious food with slimming function and preparation method thereof
CN111214641B (en) Traditional Chinese medicine preparation for treating diabetes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210528